极速赛车

April 11, 2025

Sandoz Inc. v. Amgen Inc. et al

Track this case

Case Number:

2:25-cv-00218

Court:

Virginia Eastern

Nature of Suit:

Anti-Trust

Judge:

Elizabeth W. Hanes

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 14, 2025

    Sandoz Sues Amgen Over Enbrel Biosimilar

    Sandoz accused Amgen of illegally blocking biosimilar competition to its blockbuster Enbrel drug for arthritis and other inflammatory diseases, alleging that the company used strategic acquisitions and illegal patent extensions to fend off challengers in the space and inflate U.S. prices for its drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what鈥檚 happening with clients, competitors, practice areas, and industries. 极速赛车 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login